| Cancer |
A Study for Children with Acute Lymphoblastic Leukemia Using Study Drug Carfilzomib |
Nobuko Hijiya, MD |
| Cancer |
A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab |
Luca Szalontay, MD |
| Cancer |
Study of Drug Injection with Chemotherapy in Children, Adolescents, and Young Adults with Relapse of Actue Lymphoblastic Leukemia |
Nobuko Hijiya, MD |
| Cancer |
Study Evaluating KTE-C19 in Subjects With Acute Lymphoblastic Leukemia or B-Cell Non-Hodgkin Lymphoma (ZUMA-4) |
Prakash Satwani, MD |
| Cancer |
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years) |
Luca Szalontay, MD |
| Cancer |
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors |
Luca Szalontay, MD |
| Cancer |
Study of Olanzapine in Children Receiving Chemotherapy for Hematopoietic Stem Cell Transplant (HSCT) |
Diane George, MD |
| Cancer |
Study of Flotetuzumab for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML) |
Luca Szalontay, MD |
| Cancer |
Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas) |
Luca Szalontay, MD |
| Pediatric Solid Tumors |
Study of Selinexor in Pediatric Solid Tumors, including CNS Tumors |
Luca Szalontay, MD |
| Childhood Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Sarcoma |
A Study for Patients with Malignant Peripheral Nerve Sheath Tumors Using Study Drugs PLX3397 and Sirolimus |
Gulam Manji, MD, PhD |
| Multiple Myeloma |
A study for patients with relapsed of refractory multiple myeloma using study drug KPT-330 |
Suzanne Lentzsch, MD |
| Breast Cancer |
A Study for Patients with Locally Advanced or Metastatic Breast Cancer Using Study Drug GDC-0077 |
Melissa Accordino, MD |
| Cancer |
A Study for Patients with Advanced Solid Tumors Using Study Drug BMS-986207 |
Shaheer Khan, DO |
| Breast Cancer |
Study of the role of lymph node dissection in breast cancer patients after neoadjuvant chemotherapy |
Bret Taback, MD |
| Cancer |
Collecting and growing patient tumor and blood cells from extra tissue to learn about cancer and test new drugs |
Matthew Ingham, MD |
| Cancer |
Molecular Analysis for Therapy Choice (MATCH) |
Richard Carvajal, MD |
| Pancreatic Cancer |
The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) |
Fay Kastrinos, MD |
| Cancer |
Identification of Targets for Cancer Treatment |
Andrea Califano, PhD |
| Lymphoma |
Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease |
Ran Reshef, MD |
| Breast Cancer |
Study to Predict Your Therapeutic Response (I-SPY 2 Trial) |
Meghna Trivedi, MD |
| Solid Tumors |
Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors |
Richard Carvajal, MD |
| Pancreatic Cancer |
Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) |
Gulam Manji, MD, PhD |
| Cancer |
Early Onset Malignancies Initiative (EOMI) |
Matthew Ingham, MD |
| Cancer |
Study of Atezolizumab in Alveolar Soft Part Sarcoma |
Gary Schwartz, MD |
| Liver Cancer |
A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer) |
Elizabeth Verna, MD |
| Solid Tumors |
Study of Drug PLX2853 in Subjects with Advanced Cancer |
Richard Carvajal, MD |
| Cancer |
Study of Drug (MK-2118) in Patients with Solid Tumors or Lymphomas |
Matthew Ingham, MD |
| Leukemia |
Study of Experimental Drug in Patients with Hematological Malignancies (Blood Cancers) |
Joseph Jurcic, MD |
| Pancreatic Cancer |
Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery |
Susan Bates, MD |
| Gynecologic Cancer |
Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer |
June Hou, MD |
| Cancer |
Clinical Trial Screening Tool to Address Cancer Health Disparities |
Katherine Crew, MD |
| Gastrointestinal |
Study of Standard Chemotherapy Alone or Combined with Atezolizumab for Patients with Stage III Colon Cancer |
Karie D. Runcie, MD |
| Kidney Cancer |
Study of Experimental Drug (Axitinib) in Patients with Metastatic Pheochromocytoma (PCC) or Paraganglioma |
Antonio Fojo, MD, PhD |
| Cancer |
A Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
Nicole Lamanna, MD |
| Cancer |
Study of COM701 Alone and in Combination with Nivolumain in Patients with Advanced Solid Tumors (Breast Cancer/Ovarian Cancer/Lung Cancer) |
Benjamin Izar, MD |
| Lung Cancer |
Study of Study Drug JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer |
Catherine Shu, MD |
| Prostate Cancer |
IRONMAN: International Registry for Men with Advanced Prostate Cancer |
Mark Stein, MD |
| Gastrointestinal |
Study of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer (MORPHEUS - CRC) |
Gulam Manji, MD, PhD |
| Breast Cancer |
Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer |
Melissa Accordino, MD |
| Kidney Cancer |
Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of androgen deprivation therapy followed by chemoimmunotherpy for newly metastatic hormone-sensitive prostate cancer (mHSPC) |
Mark Stein, MD |
| Solid Tumors |
Study of ASTX029 in Subjects With Advanced Solid Tumors |
Ryan Moy, MD |
| Solid Tumors |
Feasibility, Safety, and Activity Study of BPX-601 in Subjects With Previously Treated Advanced Solid Tumors |
Mark Stein, MD |
| Multiple Myeloma |
First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma |
Suzanne Lentzsch, MD |
| Bladder Cancer |
ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder |
Christopher Anderson, MD |
| Prostate Cancer |
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer |
Mark Stein, MD |
| Brain Tumors |
Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma |
Andrew Lassman, MD |
| Pancreatic Cancer |
Precision Oncology in Advanced Pancreatic Cancer |
Gulam Manji, MD, PhD |
| Solid Tumors |
Study of ASTX295 in Patients With Solid Tumors |
Gary Schwartz, MD |
| Cancer |
Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) |
Mark Stein, MD |
| Brain Tumors |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Cancer |
Study of IDE196 in Patients with Solid Tumors |
Richard Carvajal, MD |
| Cancer |
Study of Intratumorally Administered INT230-6 in Adult Subjects with Solid Tumors |
Matthew Ingham, MD |
| Breast Cancer |
ASPIRE: Study of Anastrozole, Palbociclib, Trastuzumab and Pertuzumab Metastatic Breast Cancer |
Melissa Accordino, MD |
| Skin Cancer |
Cemiplimab Survivorship Epidemiology (CASE) Study |
Richard Carvajal, MD |
| Cancer |
Study of LN-145 in the Treatment of Squamous Cell Carcinoma of the Head & Neck or Non Small Cell Lung Cancer (NSCLC) |
Richard Carvajal, MD |
| Cancer |
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices |
Grace Hillyer, EdD, MPH |
| Cancer |
LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkins Lymphoma |
Nicole Lamanna, MD |
| Breast Cancer |
ARM: Axillary Reverse Mapping - Lymph Node Surgery Technique in Breast Cancer |
Bret Taback, MD |
| Skin Cancer |
Study of Cemiplimab in Cutaneous Squamous Cell Carcinoma |
Shaheer Khan, DO |
| Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Cancer |
Study of ApricityOncology Smartphone Application Monitoring and Reporting Side Effects to their Nurses and Doctors |
Brian Henick, MD |
| Prostate Cancer |
Study of BMS-986218 + Degarelix Acetate vs. Degarelix Acetate Alone in Men with Prostate Cancer |
Karie D. Runcie, MD |
| Cancer |
Study of BA3011 in Subjects with Advanced Solid Tumors |
Matthew Ingham, MD |
| Cancer |
Study of FLX475 Alone and in Combination with Pembrolizumab in Advanced Cancer |
Jennifer Amengual, MD |
| Cancer |
Study of AMG510 in Subjects with Advanced Solid Tumors |
Catherine Shu, MD |
| COVID-19 (Coronavirus) |
COVID-19 Biobank: For People Who Have Been Tested for COVID-19 at NewYork-Presbyterian Hospital |
Muredach Reilly, MD |
| COVID-19 (Coronavirus) |
Multiple Sclerosis (MS) Patient Response to COVID-19 Outbreak: Recruiting Participants with and without MS |
Philip De Jager, PhD |
| Breast Cancer |
Study of PMD-026 in Patients with Metastatic Breast Cancer with Expansion in Metastatic Triple Negative Breast Cancer |
Meghna Trivedi, MD |
| Cancer |
Combination Therapy in KRAS-mutated Advanced Malignancies (MEKiAUTO) |
Gulam Manji, MD, PhD |
| Multiple Myeloma |
Study of PBCAR269A in Participants With Relapsed/Refractory Multiple Myeloma |
Ran Reshef, MD |
| Cancer |
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) |
Brian Henick, MD |
| Cancer |
A Study in Subjects With Advanced Cancer |
Richard Carvajal, MD |
| Breast Cancer |
Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients |
Dawn Hershman, MD |
| Leukemia |
A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy |
Amer Assal, MD |
| Cancer |
Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia |
Ran Reshef, MD |
| Lymphoma |
Study of Nivolumab Plus Standard Chemotherapy in Comparison to Brentuximab Vedotin Plus Standard Chemotherapy for Advanced Hodgkin Lymphoma |
Jennifer Amengual, MD |
| Leukemia |
A Study of CYNK-001 in Adults with Newly Diagnosed Acute Myeloid Leukemia |
Joseph Jurcic, MD |
| Cancer |
TCR-engineered T Cells in Solid Tumors (ACTengine) |
Ran Reshef, MD |
| Lung Cancer |
Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Brain Tumors |
Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) |
Andrew Lassman, MD |
| Lung Cancer |
Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer |
Simon Cheng, MD, PhD |
| Brain Tumors |
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma |
Andrew Lassman, MD |
| Cancer |
Smartphone App for Cancer Medication Adherence |
Melissa Accordino, MD |
| Lung Cancer |
Study of JNJ-93841937 Participants with Advanced Non-Small Cell Lung Cancer |
Catherine Shu, MD |
| Cancer |
Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
Richard Carvajal, MD |
| Breast Cancer |
MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care |
Katherine Crew, MD |
| Sarcoma |
Study of Paclitaxel With and Without Nivolumab and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma |
Gary Schwartz, MD |
| Cancer |
Study of ST101 in Patients with Advanced Solid Tumors |
Fabio Iwamoto, MD |
| Pancreatic Cancer |
Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma |
Gulam Manji, MD, PhD |
| Cancer |
Study of RTX-240 in Adults with Relapsed/Refractory or Locally Advanced Solid Tumors |
Mark Stein, MD |
| Bladder Cancer |
Study of Intravesical Cabazitaxel, Gemcitabine and Cisplatin (CGC) in the Treatment of Urothelial Carcinoma (Bladder Cancer) |
Joel DeCastro, MD, MPH |
| Cancer |
Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers |
Benjamin Izar, MD |
| Lung Cancer |
Study of Amivantamab and Carboplatin-Pemetrexed Therapy, versus Carboplatin-Pemetrexed, in Participants With Non-Small Cell Lung Cancer |
Catherine Shu, MD |
| Lung Cancer |
Study of Durvalumab with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC (MeRmaiD-1) |
Catherine Shu, MD |
| Kidney Cancer |
Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition |
Mark Stein, MD |
| Sarcoma |
Study of Envafolimab in Patients with Sarcoma or Myxofibrosarcoma |
Gary Schwartz, MD |
| Cancer |
A First-in-Human Study of CDK-002 (exoSTING) in Subjects with Advanced/Metastatic Solid Tumors |
Matthew Ingham, MD |
| Lung Cancer |
Study of Combining Osimertinib with and without Ramucirumab in Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Brain Tumors |
Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for Treatment of Newly Diagnosed Glioblastoma |
Fabio Iwamoto, MD |
| Squamous Cell Carcinoma |
Study of Ruxolitinib in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma |
Richard Carvajal, MD |
| Brain Tumors |
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary Central Nervous System (CNS) Lymphoma |
Aya Haggiagi, MD |
| Cancer |
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer |
Bret Taback, MD |
| Melanoma |
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma |
Benjamin Izar, MD |
| Cancer |
A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors |
Matthew Ingham, MD |
| Prostate Cancer |
Study of Abiraterone Acetate, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer |
Mark Stein, MD |
| Cancer |
A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors |
Richard Carvajal, MD |
| Lung Cancer |
Tomivosertib With Anti-PD-(L)1 in Subjects With Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Cancer |
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer |
Brian Henick, MD |
| Autoimmune Disorders |
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer |
Brian Henick, MD |
| Cancer |
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors |
Benjamin Izar, MD |
| Prostate Cancer |
PLX2853 with Abiraterone Acetate, Prednisone, and Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Mark Stein, MD |
| Cancer |
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors |
Ryan Moy, MD |
| Lymphoma |
Dose-escalation Safety Study of PBCAR19B in Participants With CD19-expressing Malignancies (Non Hodgkin Lymphoma) |
Ran Reshef, MD |
| Brain Tumors |
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects |
Fabio Iwamoto, MD |
| Cancer |
LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors |
Gulam Manji, MD, PhD |
| Brain Tumors |
ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma |
Fabio Iwamoto, MD |
| Pancreatic Cancer |
Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) |
Susan Bates, MD |
| Cancer |
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Cancer |
Benjamin Izar, MD |
| Lung Cancer |
Study of Osimertinib (TAGRISSOTM) in Non-Small Cell Lung Cancer (NeoADAURA) Patients |
Catherine Shu, MD |
| Melanoma |
Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease |
Shaheer Khan, DO |
| Cancer |
Study of AB928 in Combination with Other Therapies for Patients with Metastatic Colon Cancer (mCRC) |
Gulam Manji, MD, PhD |
| Cancer |
Study of BAY 1895344 in Combination with Chemotherapy for Patients with Metastatic Gastrointestinal Cancer |
Ryan Moy, MD |
| Cancer |
Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer |
David Horowitz, MD |
| Cancer |
Study of New Oral Anti-Cancer Drug (OACD) |
Dawn Hershman, MD |
| Cancer |
First-in-Human Study of DS-7300a in Subjects with Advanced Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of ADXS-504 in Patients with Prostate Cancer |
Mark Stein, MD |
| Cancer |
Study of MPT-0118 Alone or in Combination with Keytruda in Patients with Advanced or Metastatic Cancer |
Shaheer Khan, DO |
| Cancer |
Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses |
Dawn Hershman, MD |
| Breast Cancer |
Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors |
Dawn Hershman, MD |
| Breast Cancer |
Study of Improving Patient-Centered Communication in Patients with Breast Cancer |
Bret Taback, MD |
| Brain Tumors |
Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma |
Mary Welch, MD |
| Cancer |
Study of INCB106385 Alone or in Combination with INCMGA00012 in Patients with Advanced Cancer |
Mark Stein, MD |
| Obstetrics & Gynecology |
Study of Pembrolizumab in Combination with Chemotherapy for Patients with Endometrial Cancer |
Jason Wright, MD |
| Lung Cancer |
Study of Atezolizumab and Tiragolumab Alone or in Combination with Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Leukemia |
Study of BGB-11417 in Patients with Leukemia |
Nicole Lamanna, MD |
| Lung Cancer |
Study in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) whose Disease has Gotten Worse After Osermitinib Treatment |
Catherine Shu, MD |
| Gastrointestinal |
Study of RO7198457 for Patients Who Have Had Surgery for Stage II and Stage III Colon Cancer |
Karie D. Runcie, MD |
| Breast Cancer |
Study of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple-Negative Breast Cancer |
Meghna Trivedi, MD |
| Melanoma |
A First-in-Human Study Using FHD-286 in Patients with Metastatic Uveal Melanoma |
Richard Carvajal, MD |
| Cancer |
Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer |
Benjamin Herzberg, MD |
| Pancreatic Cancer |
Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer |
Susan Bates, MD |
| Brain Cancer |
Study of ONC201 in Adults With Recurrent H3 K27M-mutant Glioma |
Andrew Lassman, MD |
| Brain Cancer |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Brain Cancer |
Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) |
Andrew Lassman, MD |
| Brain Cancer |
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma |
Andrew Lassman, MD |
| Brain Cancer |
Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma |
Fabio Iwamoto, MD |
| Brain Cancer |
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary Central Nervous System (CNS) Lymphoma |
Aya Haggiagi, MD |
| Brain Cancer |
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects |
Fabio Iwamoto, MD |
| Brain Cancer |
ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma |
Mary Welch, MD |
| Cancer |
Study of Ulixertinib (BVD-523) for Patients with Advanced Cancer that Show Genetic Alterations |
Richard Carvajal, MD |
| Cancer |
Study of PF-07263689 Alone or in Combination with Sasanlimab for Patients with Advanced Cancer |
Brian Henick, MD |
| Bladder Cancer |
First-in-Human Study of PF-07225570 Alone or in Combination with Sasanlimab for Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) |
Joel DeCastro, MD, MPH |
| Lung Cancer |
Study of Capmatinib for Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Breast Cancer |
Decreasing Chemotherapy for HER2 Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy |
Julia McGuinness, MD |
| Cancer |
Study of IDE397 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Lung Cancer |
Study of Pembrolizumab Alone or in Combination with Chemotherapy in Older Patients with Non-Small Cell Lung Cancer |
Catherine Shu, MD |
| Lung Cancer |
Liver-Directed Radiotherapy Along with Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) and Liver Metastases |
Brian Henick, MD |
| Breast Cancer |
Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer |
Julia McGuinness, MD |
| Depression |
Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer |
John Markowitz, MD |
| Cancer |
Study of RP-6306 in Combination with Gemcitabine (Chemotherapy) for Patients with Advanced Solid Tumors |
Ryan Moy, MD |
| Leukemia |
Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) |
Ran Reshef, MD |
| Brain Cancer |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Brain Tumors |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Lung Cancer |
Study of Berzosertib Compared to Chemotherapy for Patients with Non-Small Cell Lung Cancer |
Benjamin Herzberg, MD |
| Prostate Cancer |
Study of JNJ-75229414 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Mark Stein, MD |
| Breast Cancer |
Intervention to Improve Medication Scheduling for Patients with Breast Cancer |
Dawn Hershman, MD |
| Prostate Cancer |
Study of BMS-986218 Alone or in Combination with Nivolumab for Male Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Karie D. Runcie, MD |
| Cancer |
Study of CS5001 in Patients with Advanced Solid Tumors |
Richard Carvajal, MD |
| Breast Cancer |
Study of RLY-2608 in Patients with Breast Cancer |
Julia McGuinness, MD |
| Sarcoma |
Study of ATX-101 in Patients with Dedifferentiated Liposarcoma (LPS) and Leiomyosarcoma (LMS) |
Matthew Ingham, MD |
| Melanoma |
Study of ALKS 4230 in Patients with Previously Treated Advanced Melanoma |
Benjamin Izar, MD |
| Prostate Cancer |
Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer |
Mark Stein, MD |
| Brain Cancer |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Brain Tumors |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Breast Cancer |
Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) |
Eileen Connolly, MD, PhD |
| Sarcoma |
Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma |
Matthew Ingham, MD |
| Lymphoma |
Study of Venetoclax in Addition to Usual Treatment for Patients with Waldenstrm's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) |
Divaya Bhutani, MD |
| Cancer |
Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) |
Ryan Moy, MD |
| Prostate Cancer |
Study of Cabozantinib in Patients with Prostate Cancer who Previously Received Anti-Androgen Therapy |
Mark Stein, MD |
| Lymphoma |
Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) |
Jennifer Amengual, MD |
| Lymphoma |
Study of TAK-007 in Patients with Non-Hodgkin Lymphoma |
Ran Reshef, MD |
| Cancer |
Study of GSK3901961 and GSK3845097 in Patients with Synovial Sarcoma or Non-Small Cell Lung Cancer (NSCLC) |
Matthew Ingham, MD |
| Breast Cancer |
Study of GLSI-100 in Female Patients with Breast Cancer |
Julia McGuinness, MD |
| Cancer |
Study of BT7480 in Patients with Advanced Cancer |
Richard Carvajal, MD |
| Cancer |
Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation |
Benjamin Herzberg, MD |
| Lymphoma |
Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) |
Jennifer Amengual, MD |
| Cancer |
Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors |
Benjamin Izar, MD |
| Breast Cancer |
Study of Imprime PGG and Pembrolizumab (Keytruda) in Patients with Metastatic Breast Cancer (mBCA) |
Julia McGuinness, MD |
| Sarcoma |
Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma |
Gary Schwartz, MD |
| Breast Cancer |
Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation |
Katherine Crew, MD |
| Lymphoma |
Study of Pembrolizumab, Ibrutinib and Rituximab in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Cancer |
Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers |
Matthew Dallos, MD |
| Cancer |
Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma |
June Hou, MD |
| Leukemia |
Study of Bendamustine/Rituximab Induction Followed by Venetoclax and Rituximab Consolidation for Treatment of Chronic Lymphocytic Leukemia |
Nicole Lamanna, MD |
| Cancer |
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers |
Richard Carvajal, MD |
| Lymphoma |
Study of LOXO-305 in Patients with Mantle Cell Lymphoma (MCL) |
Andrew Lipsky, MD |
| Cancer |
ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma |
Ran Reshef, MD |
